Verana Health and Guardant Health partnered to provide biopharma researchers with connected precision medicine data assets spanning regulatory-grade electronic health record cohorts and clinicogenomic testing. The collaboration is intended to help researchers link tumor biology and therapy response with longitudinal real-world outcomes across solid tumors such as lung, breast, and colorectal cancer, with the goal of accelerating biomarker validation and therapy development.